| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2020 | Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, et al. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nature Communications. 11: 338. PMID 31953400 DOI: 10.1038/S41467-019-14219-6 | 0.345 | |||
| 2019 | Bhave SR, Luke JJ, Lemons J, Zha Y, Carll TC, Krausz T, Liang H, Janisch LA, Hseu RD, Khodarev N, Weichselbaum RR, Pitroda S, Chmura SJ. Long-term clinical outcomes and transcriptional analysis following partial and complete tumor SBRT plus pembrolizumab. Journal of Clinical Oncology. 37: 34-34. DOI: 10.1200/Jco.2019.37.8_Suppl.34 | 0.337 | |||
| 2018 | Lemons J, Luke JJ, Karrison T, Pitroda S, Melotek J, Zha Y, Al-Hallaq HA, Arina A, Janisch LA, Chang PJ, Patel JD, Fleming GF, Moroney JW, Sharma M, White JR, et al. Safety and clinical activity of pembrolizumab immunotherapy and multi-organ site ablative stereotactic body radiotherapy (iMOSART) in patients with advanced solid tumors. Journal of Clinical Oncology. 36: 20-20. DOI: 10.1200/Jco.2018.36.5_Suppl.20 | 0.321 | |||
| 2016 | Rajabi H, Tagde A, Alam M, Bouillez A, Pitroda S, Suzuki Y, Kufe D. DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells. Oncogene. PMID 27212035 DOI: 10.1038/Onc.2016.180 | 0.318 | |||
| 2016 | Bouillez A, Rajabi H, Pitroda S, Jin C, Alam M, Kharbanda A, Tagde A, Wong KK, Kufe D. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas. Cancer Research. 76: 1538-48. PMID 26833129 DOI: 10.1158/0008-5472.Can-15-1804 | 0.371 | |||
| 2015 | Takahashi H, Jin C, Rajabi H, Pitroda S, Alam M, Ahmad R, Raina D, Hasegawa M, Suzuki Y, Tagde A, Bronson RT, Weichselbaum R, Kufe D. MUC1-C activates the TAK1 inflammatory pathway in colon cancer. Oncogene. PMID 25659581 DOI: 10.1038/Onc.2014.442 | 0.352 | |||
| 2014 | Widau RC, Parekh AD, Ranck MC, Golden DW, Kumar KA, Sood RF, Pitroda SP, Liao Z, Huang X, Darga TE, Xu D, Huang L, Andrade J, Roizman B, Weichselbaum RR, et al. RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation. Proceedings of the National Academy of Sciences of the United States of America. 111: E484-91. PMID 24434553 DOI: 10.1016/J.Ijrobp.2014.05.623 | 0.348 | |||
| 2012 | Jin C, Rajabi H, Pitroda S, Li A, Kharbanda A, Weichselbaum R, Kufe D. Cooperative interaction between the MUC1-C oncoprotein and the Rab31 GTPase in estrogen receptor-positive breast cancer cells. Plos One. 7: e39432. PMID 22792175 DOI: 10.1371/Journal.Pone.0039432 | 0.34 | |||
| 2011 | Khodarev N, Pitroda S, Sood R, Khan S, Filippo M, Gutt R, Perakis S, Darga T, Malik R, Pederson A, Weichselbaum R. Abstract 573: Ionizing radiation activates IFN signaling in tumor cells Cancer Research. 71: 573-573. DOI: 10.1158/1538-7445.Am2011-573 | 0.339 | |||
| 2010 | Khodarev N, Ahmad R, Rajabi H, Pitroda S, Kufe T, McClary C, Joshi MD, MacDermed D, Weichselbaum R, Kufe D. Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer. Oncogene. 29: 920-9. PMID 19915608 DOI: 10.1038/Onc.2009.391 | 0.363 | |||
| Show low-probability matches. | |||||